Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 21;135(1):110-134.
doi: 10.1161/CIRCRESAHA.123.323939. Epub 2024 May 29.

Early Injury Landscape in Vein Harvest by Single-Cell and Spatial Transcriptomics

Affiliations

Early Injury Landscape in Vein Harvest by Single-Cell and Spatial Transcriptomics

Marina E Michaud et al. Circ Res. .

Abstract

Background: Vein graft failure following cardiovascular bypass surgery results in significant patient morbidity and cost to the healthcare system. Vein graft injury can occur during autogenous vein harvest and preparation, as well as after implantation into the arterial system, leading to the development of intimal hyperplasia, vein graft stenosis, and, ultimately, bypass graft failure. Although previous studies have identified maladaptive pathways that occur shortly after implantation, the specific signaling pathways that occur during vein graft preparation are not well defined and may result in a cumulative impact on vein graft failure. We, therefore, aimed to elucidate the response of the vein conduit wall during harvest and following implantation, probing the key maladaptive pathways driving graft failure with the overarching goal of identifying therapeutic targets for biologic intervention to minimize these natural responses to surgical vein graft injury.

Methods: Employing a novel approach to investigating vascular pathologies, we harnessed both single-nuclei RNA-sequencing and spatial transcriptomics analyses to profile the genomic effects of vein grafts after harvest and distension, then compared these findings to vein grafts obtained 24 hours after carotid-carotid vein bypass implantation in a canine model (n=4).

Results: Spatial transcriptomic analysis of canine cephalic vein after initial conduit harvest and distention revealed significant enrichment of pathways (P<0.05) involved in the activation of endothelial cells (ECs), fibroblasts, and vascular smooth muscle cells, namely pathways responsible for cellular proliferation and migration and platelet activation across the intimal and medial layers, cytokine signaling within the adventitial layer, and ECM (extracellular matrix) remodeling throughout the vein wall. Subsequent single-nuclei RNA-sequencing analysis supported these findings and further unveiled distinct EC and fibroblast subpopulations with significant upregulation (P<0.05) of markers related to endothelial injury response and cellular activation of ECs, fibroblasts, and vascular smooth muscle cells. Similarly, in vein grafts obtained 24 hours after arterial bypass, there was an increase in myeloid cell, protomyofibroblast, injury response EC, and mesenchymal-transitioning EC subpopulations with a concomitant decrease in homeostatic ECs and fibroblasts. Among these markers were genes previously implicated in vein graft injury, including VCAN, FBN1, and VEGFC, in addition to novel genes of interest, such as GLIS3 and EPHA3. These genes were further noted to be driving the expression of genes implicated in vascular remodeling and graft failure, such as IL-6, TGFBR1, SMAD4, and ADAMTS9. By integrating the spatial transcriptomics and single-nuclei RNA-sequencing data sets, we highlighted the spatial architecture of the vein graft following distension, wherein activated and mesenchymal-transitioning ECs, myeloid cells, and fibroblasts were notably enriched in the intima and media of distended veins. Finally, intercellular communication network analysis unveiled the critical roles of activated ECs, mesenchymal-transitioning ECs, protomyofibroblasts, and vascular smooth muscle cells in upregulating signaling pathways associated with cellular proliferation (MDK [midkine], PDGF [platelet-derived growth factor], VEGF [vascular endothelial growth factor]), transdifferentiation (Notch), migration (ephrin, semaphorin), ECM remodeling (collagen, laminin, fibronectin), and inflammation (thrombospondin), following distension.

Conclusions: Vein conduit harvest and distension elicit a prompt genomic response facilitated by distinct cellular subpopulations heterogeneously distributed throughout the vein wall. This response was found to be further exacerbated following vein graft implantation, resulting in a cascade of maladaptive gene regulatory networks. Together, these results suggest that distension initiates the upregulation of pathological pathways that may ultimately contribute to bypass graft failure and presents potential early targets warranting investigation for targeted therapies. This work highlights the first applications of single-nuclei and spatial transcriptomic analyses to investigate venous pathologies, underscoring the utility of these methodologies and providing a foundation for future investigations.

Keywords: coronary artery bypass; endothelium; hyperplasia; single-cell analysis; spatial analysis; vascular grafting.

PubMed Disclaimer

Conflict of interest statement

Disclosures None.

Figures

Figure 1.
Figure 1.
Overview of the workflow used for sample analysis. A, Canine vein graft samples were retrieved following distension, then analyzed via single-nuclei RNA-seq (snRNA-seq) and spatial transcriptomics (ST) through the 10× Genomics platform. Single-nuclei-based transcriptomics enables the sequencing of difficult-to-dissociate samples while preserving detailed individual cellular resolution. As a complementary approach, ST provides insight into the spatial gene expression of the tissue, with the transcriptomes of 1 to 10 cells captured per barcoded spot of the sample slide. Combined, these approaches illuminate the unique cellular architecture and transcriptomic landscape of the tissue. B, Varying permeabilization times were assessed for fluorescent cDNA footprint to optimize tissue permeabilization. The left panel shows the brightfield images (hematoxylin and eosin [H&E]), and the right panel shows fluorescent images (Cy3, Cy5 multispectral imaging [MSI]). C, Images of H&E strained veins. Notably, the lower panel illustrates the expansion of the lumen following distension. D, Overview of the developed method for adding histological annotations to ST samples for targeted downstream analyses. Capture spots are projected onto the H&E image as voxels, generating a spatial plot that can be annotated with STannotate and used for analysis. CABG indicates coronary artery bypass grafting; IHC, immunohistochemistry; and OCT, optimal cutting temperature compound.
Figure 2.
Figure 2.
Spatial transcriptomic analysis of distended veins. A, Top, Spatial plots displaying capture spots (voxels) projected onto hematoxylin and eosin (H&E) images of representative control (C3_ST1 left) and distended (C3_ST2, right) veins from the same canine (C3), annotated using our ST annotation tool. Bottom, Volcano plot of significantly differentially expressed genes (P<0.05) within the distended vein compared with the control vein, wherein each gene is colored according to the vein wall layer with the highest expression of the marker. B, Enriched pathways (via Reactome database) within each layer of the distended veins compared with control veins, based on significantly upregulated genes between each layer (P<0.05). C, Network of key differentially expressed genes and associated pathways (P<0.05) between control and distended veins, derived from clusterProfiler analysis using the Reactome pathways database. CIT indicates citron kinase; ECM, extracellular matrix; GP1b-IX-V, glycoprotein (GP) Ib-IX-V; MET, mesenchymal-epithelial transition; ROCK, Rho-associated protein kinase; and SEMA4D, semaphorin 4D.
Figure 3.
Figure 3.
Spatial clustering of control and distended veins. A, Uniform manifold approximation and projection (UMAP) displaying the clustering of spatial transcriptomic voxels (containing 1–10 cells each) derived from control and distended veins. Clusters are derived based on similar transcriptomic profiles correlating to similar cell type compositions. Cluster labels were designated by the predominant localization of associated voxels to either the intima (I), media (M), or adventitia (A) of the vein samples. The spatial distribution of these clusters was then mapped onto the vein samples. B, Mapping of spatial clusters onto a representative control vein sample (C3_ST1). C, Mapping of spatial clusters onto a distended vein sample (C3_ST2) from the same canine (C3). D, Relative proportions of each spatial cluster present within control vein and distended vein groups. E, Heatmap of marker genes associated with different spatial clusters. Columns represent individual voxels grouped by spatial cluster, while rows display individual genes. Horizontal colored bars above the heatmap indicate the different spatial cellular clusters. Relative gene expression is shown in pseudo color, where blue represents low expression and red represents high expression. Enriched biological pathways (via clusterProfiler using Reactome database) based on differentially upregulated genes between the (F) M1 and M2 clusters, as well as the (G) A1 and A2 clusters (P<0.05). Gene ratio is defined as the proportion of upregulated genes present in the cluster that overlap with the respective pathway. ECM indicates extracellular matrix; EPH, erythropoietin-producing human hepatocellular receptors; GP1b-IX-V, glycoprotein (GP) Ib-IX-V; L1CAM, L1 cell adhesion molecule; NGF, nerve growth factor; and MAPK, mitogen-activated protein kinase.
Figure 4.
Figure 4.
Single-nuclei transcriptomic analysis of control and distended veins. A, Uniform manifold approximation and projection (UMAP) displaying the clustering of nuclei derived from control and distended veins. Canonical cell types are based on the expression of marker genes (Figure S3). B, Relative proportions of each cluster present within control vein and distended vein groups. C, Volcano plot of differentially expressed genes within the distended vein compared with the control vein (P<0.05), wherein each gene is colored according to the cluster with the highest expression of the marker. D, Heatmap of top marker genes associated with different cell types. Columns represent individual cells grouped by cell types, while rows display individual genes. Horizontal colored bars above the heatmap indicate the different cell types. Relative gene expression is shown in pseudo color, where blue represents low expression and red represents high expression. Top marker genes for clusters are defined by the average log2-fold-change of genes expressed in >30% of nuclei within a cluster and P<0.05. E, Network of key differentially enriched pathways between clusters, derived from clusterProfiler analysis using the Reactome database (P<0.05). Each node depicts the proportion of each cluster displaying enrichment of the associated pathway and the cumulative number of genes enriched in the pathway between the represented clusters. ECM indicates extracellular matrix; ER, endoplasmic reticulum; MET, mesenchymalepithelial transition; NOTCH4, neurogenic locus notch homolog protein 4; PDGF, platelet-derived growth factor; and RAC1, Rac Family Small GTPase 1.
Figure 5.
Figure 5.
Characterization of fibroblast subpopulations. A, Volcano plot of differentially expressed genes within fibroblast subclusters of the distended vein compared with the control vein (P<0.05), wherein each gene is colored according to the fibroblast subpopulation with the highest expression of the marker. B, Heatmap of top marker genes associated with different fibroblast subclusters. Columns represent individual cells grouped by cell types, while rows display individual genes. Horizontal colored bars above the heatmap indicate the different cell types. Relative gene expression is shown in pseudo color, where blue represents low expression and red represents high expression. Top markers for each fibroblast cluster are defined by the average log2-fold-change and P<0.05. C, Relative proportions of each fibroblast subpopulation present within control vein and distended vein groups. D, Dot plot of the top markers representing the phenotype of each fibroblast subpopulation. The relative expression and percent of cells expressing specific markers are shown by shades of blue and the dot size, respectively.
Figure 6.
Figure 6.
Characterization of endothelial cell (EC) subpopulations. A, Volcano plot of differentially expressed genes within ECs of the distended vein compared with the control vein, wherein each gene is colored according to the EC subpopulation with the highest expression of the marker. B, Heatmap of top marker genes associated with different endothelial subclusters. Columns represent individual cells grouped by cell types, while rows display individual genes. Horizontal colored bars above the heatmap indicate the different cell types. Relative gene expression is shown in pseudo color, where blue represents low expression and red represents high expression. Top marker genes between endothelial clusters are defined by the average log2-fold-change and P<0.05. C, Relative proportions of each EC subpopulation present within control and distended vein groups. D, Dot plot of the top markers representing the phenotype of each EC subpopulation. The relative expression and percent of cells expressing specific markers are shown by shades of blue and the dot size, respectively.
Figure 7.
Figure 7.
Deconvolution of spatial transcriptomic data through the integration of single-nuclei data. A, Summary of distinct fibroblast (FB) and endothelial subpopulations identified in control and distended veins via single-nuclei RNA-sequencing (snRNA-seq) analysis along with expression ok key markers. B, Heatmap displaying the differential enrichment scores of cellular subpopulations across layers of vein wall following distension. An increased differential score (red) indicates increased gene signature expression associated with the respective subpopulation in the distended veins relative to control veins, and blue indicates increased enrichment in control veins. C, Heatmap of neighborhood enrichment z scores generated via Squidpy, illustrating the proximity of cellular populations to one another based on the dominant cell type assigned to each voxel. Red indicates enriched proximity between 2 populations, whereas blue indicates depleted proximity. D, Spatial plots of the representative paired samples of control (C3_ST1) and distended (C3_ST2) veins displaying the dominant cell type within each voxel predicted by model-based deconvolution of the spatial transcriptomic data using the single-nuclei dataset via Cell2location. E, Validation of the enrichment score (left) and model-based (D) integration approaches using RNAScope (right). EC indicates endothelial cell; DAPI, 4′,6-diamidino-2-phenylindole; FBN1, fibrillin 1; and LMCD1, LIM and cysteine rich domains 1.
Figure 8.
Figure 8.
Relationship of preimplantation and postimplantation transcriptomic profiles and select protein expression. A, Relative proportions of each fibroblast subpopulation present within control vein and distended vein groups. B, Spatial plot of grafted vein sample displaying the dominant cell type within each voxel based on deconvolution of the spatial transcriptomic data using the single-nuclei data set via Cell2location. C, Temporally resolved multilayer gene network analysis illustrating the effects of key genes (circled) at the time of vein harvesting and distension (left) to 24-hour postimplantation (right). The color scale of the gene nodes represents the closeness centrality of the node, a measure of how close a node is relative to all other nodes in the network, wherein a higher closeness centrality indicates a higher capacity for interactions with other genes, suggesting functional or regulatory importance. D, Immunohistochemistry staining of control, distended, and grafted veins with VCAN (versican), GLIS3 (GLIS family zinc finger 3), or FBN (fibrillin 1) with quantification values (left). EC indicates endothelial cell; ECM, extracellular matrix; and SMC, smooth muscle cell.

Comment in

Similar articles

References

    1. Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, et al. . Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145:e153–e639. doi: 10.1161/CIR.0000000000001052 - PubMed
    1. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, et al. ; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2021 update: a report from the American Heart Association. Circulation. 2021;143:e254–e743. doi: 10.1161/CIR.0000000000000950 - PubMed
    1. Almasri J, Adusumalli J, Asi N, Lakis S, Alsawas M, Prokop LJ, Bradbury A, Kolh P, Conte MS, Murad MH. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. J Vasc Surg. 2019;69:126S–136S. doi: 10.1016/j.jvs.2018.01.071 - PubMed
    1. Martínez-González B, Reyes-Hernández CG, Quiroga-Garza A, Rodríguez-Rodríguez VE, Esparza-Hernández CN, Elizondo-Omaña RE, Guzmán-López S. Conduits used in coronary artery bypass grafting: a review of morphological studies. Ann Thorac Cardiovasc Surg. 2017;23:55–65. doi: 10.5761/atcs.ra.16-00178 - PMC - PubMed
    1. Widimsky P, Straka Z, Stros P, Jirasek K, Dvorak J, Votava J, Lisa L, Budesinsky T, Kolesar M, Vanek T, et al. . One-year coronary bypass graft patency: a randomized comparison between off-pump and on-pump surgery angiographic results of the PRAGUE-4 trial. Circulation. 2004;110:3418–3423. doi: 10.1161/01.CIR.0000148139.79580.36 - PubMed
-